HIGHLIGHTS
SUMMARY
The etiology of liver disease is moving from viral hepatitis-which is properly treated by vaccines or medications-to fatty liver disease, which is probably 2 of 11 a result of the rising incidence of metabolic syndrome. The weight loss and rapid mobilization of liver fat demonstrated using VLCKD could serve as an effective alternative for the treatment of NAFLD. This study evaluated the effectiveness of eight weeks of VLCKD on modifications to the liver and metabolic biomarkers linked to NAFLD in a group of obese/overweight patients without evident comorbidities. Metabolic parameters, such . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.